Lake Street Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $32
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
Lake Street initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces Price Target of $32.
Lake Street initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces Price Target of $32.